These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 29056004)
1. [Research advances in the treatment of hepatic fibrosis]. Xia L; Yang CQ Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):566-570. PubMed ID: 29056004 [TBL] [Abstract][Full Text] [Related]
2. [Reversibility of hepatic fibrosis]. van der Meer AJ; Sonneveld M; Schouten JN; Janssen HL Ned Tijdschr Geneeskd; 2014; 158():A6790. PubMed ID: 24594125 [TBL] [Abstract][Full Text] [Related]
4. A target role for mast cell in the prevention and therapy of hepatic fibrosis. Shen DZ Med Hypotheses; 2008; 70(4):760-4. PubMed ID: 17919831 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? Fallowfield J; Hayes P Clin Med (Lond); 2011 Apr; 11(2):179-83. PubMed ID: 21526707 [No Abstract] [Full Text] [Related]
7. Reversal of liver cirrhosis: current evidence and expectations. Jung YK; Yim HJ Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717 [TBL] [Abstract][Full Text] [Related]
8. Development and Regression of Cirrhosis. Saffioti F; Pinzani M Dig Dis; 2016; 34(4):374-81. PubMed ID: 27170391 [TBL] [Abstract][Full Text] [Related]
9. Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background. Bortolotti F; Guido M J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):401-6. PubMed ID: 17414134 [TBL] [Abstract][Full Text] [Related]
10. Evolving strategies for liver fibrosis staging: Non-invasive assessment. Stasi C; Milani S World J Gastroenterol; 2017 Jan; 23(2):191-196. PubMed ID: 28127192 [TBL] [Abstract][Full Text] [Related]
11. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy. Omar R; Yang J; Liu H; Davies NM; Gong Y Rev Physiol Biochem Pharmacol; 2016; 172():1-37. PubMed ID: 27534415 [TBL] [Abstract][Full Text] [Related]
12. [Consensus on the diagnosis and therapy of hepatic fibrosis in]. ; ; Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):657-667. PubMed ID: 31594088 [TBL] [Abstract][Full Text] [Related]
14. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. Bosserhoff A; Hellerbrand C Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008 [TBL] [Abstract][Full Text] [Related]
15. Hepatic Fibrosis in Dogs. Eulenberg VM; Lidbury JA J Vet Intern Med; 2018 Jan; 32(1):26-41. PubMed ID: 29194760 [TBL] [Abstract][Full Text] [Related]
16. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential. Kong D; Zhang F; Zhang Z; Lu Y; Zheng S Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010 [TBL] [Abstract][Full Text] [Related]
18. Consensus on the diagnosis and treatment of hepatic fibrosis (2019). Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association J Dig Dis; 2020 Mar; 21(3):127-138. PubMed ID: 32108989 [TBL] [Abstract][Full Text] [Related]
19. Current research of hepatic cirrhosis in China. Yao XX; Jiang SL; Yao DM World J Gastroenterol; 2005 Feb; 11(5):617-22. PubMed ID: 15655809 [TBL] [Abstract][Full Text] [Related]
20. The spleen in liver cirrhosis: revisiting an old enemy with novel targets. Li L; Duan M; Chen W; Jiang A; Li X; Yang J; Li Z J Transl Med; 2017 May; 15(1):111. PubMed ID: 28535799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]